Eric Jincai Zhang

Eric Jincai Zhang is a Principal at Patient Square Capital, with additional roles as a Board Observer for Summit BHC, Radius Health, Inc., and Resolve Biosciences, all commencing in June 2023. Previously, Eric served as Vice President at TPG from August 2019 to January 2023 and held various positions including Member of the Board of Directors at DOC GENERICI and Ellodi Pharmaceuticals. Eric began a finance career as an Analyst at Goldman Sachs in Healthcare Investment Banking from July 2013 to June 2015. Academic credentials include an MBA from Stanford University Graduate School of Business, a Bachelor of Arts in Mathematics and Economics from Northwestern University, and an Undergraduate Certificate in Financial Economics from Northwestern University's Kellogg School of Management.